Title : Suppression of DLBCL Progression by the E3 Ligase Trim35 Is Mediated by CLOCK Degradation and NK Cell Infiltration.

Pub. Date : 2021

PMID : 34124276






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The majority of diffuse large B-cell lymphoma (DLBCL) patients develop relapsed or refractory disease after standard ruxolitinib, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy, which is partly related to a dysregulated tumor immune microenvironment. Doxorubicin DNA damage inducible transcript 3 Homo sapiens